Evidence map›Paper›PMID 41483250›Full record

Observational studyNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2026

Megalencephalic leukoencephalopathy with subcortical cysts: a multicenter Italian experience.

Jacopo Sartorelli, Davide Tonduti, Elena Ambrosini, Eleonora Bonaventura, Luisa Vercellino, Ylenia Vaia, Fabio Bruschi, Francesca Pochiero, Elena Procopio, Alessandro Simonati and 10 more

Abstract readMulticenter StudyObservational Study
PubMed Publisher
In one paragraph

Observational study in Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Jacopo SartorelliUnit of Muscular and Neurodegenerative Diseases, IRCCS Bambino Gesù Children's Hospital, Rome, 00165, Italy.
Davide TondutiLeukodystrophy Group of the National Virtual Institute for Rare Diseases of the Italian Neuroscience Network (RIN), Milan, Italy.
Elena AmbrosiniDepartment of Neuroscience, Istituto Superiore di Sanità, Rome, Italy.
Eleonora BonaventuraLeukodystrophy Group of the National Virtual Institute for Rare Diseases of the Italian Neuroscience Network (RIN), Milan, Italy.
Luisa VercellinoUnit of Pediatric Neurology, COALA (Center for Diagnosis and Treatment of Leukodystrophies), V. Buzzi Children's Hospital, Milan, Italy.
Ylenia VaiaLeukodystrophy Group of the National Virtual Institute for Rare Diseases of the Italian Neuroscience Network (RIN), Milan, Italy.
Fabio BruschiLeukodystrophy Group of the National Virtual Institute for Rare Diseases of the Italian Neuroscience Network (RIN), Milan, Italy.
Francesca PochieroInborn Metabolic and Muscular Disorders Unit, Anna Meyer Children Hospital IRCCS, Florence, Italy.
Elena ProcopioInborn Metabolic and Muscular Disorders Unit, Anna Meyer Children Hospital IRCCS, Florence, Italy.
Alessandro SimonatiDepartment of Surgery, Dentistry, Paediatrics and Gynaecology, University of Verona, Verona, Italy.
Isabella MoroniLeukodystrophy Group of the National Virtual Institute for Rare Diseases of the Italian Neuroscience Network (RIN), Milan, Italy.
Federica Rachele DantiLeukodystrophy Group of the National Virtual Institute for Rare Diseases of the Italian Neuroscience Network (RIN), Milan, Italy.
Mariasavina SeverinoNeuroradiology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Marina Martinez PoppleChild Neuropsychiatry Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Salvatore RossiDepartment of Neurosciences, Università Cattolica del Sacro Cuore, Rome, Italy.
Gabriella SilvestriLeukodystrophy Group of the National Virtual Institute for Rare Diseases of the Italian Neuroscience Network (RIN), Milan, Italy.
Livia GaravelliMedical Genetics Unit, Azienda USL-IRCCS of Reggio Emilia, Reggio Emilia, Italy.
Simona MadeoDepartment of Medical and Surgical Sciences for Mothers, Children and Adults, Pediatric Unit, University of Modena and Reggio Emilia, Modena, Italy.
Enrico BertiniUnit of Muscular and Neurodegenerative Diseases, IRCCS Bambino Gesù Children's Hospital, Rome, 00165, Italy.
Francesco NicitaUnit of Muscular and Neurodegenerative Diseases, IRCCS Bambino Gesù Children's Hospital, Rome, 00165, Italy. francesco.nicita@opbg.net.ORCID http://orcid.org/0000-0002-5612-821X

Funding

Association Européenne contre les Leucodystrophies 2024-002C4AMinistero della Salute Current Research funds
6 · The paper itself

Abstract

backgroundMegalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare inherited white matter disorder. Initially, a "classic" phenotype has been characterized, presenting early-onset macrocephaly, cerebellar ataxia, mild spasticity, and a distinctive neuroimaging pattern of diffuse white matter abnormalities with subcortical cysts. An "improving" phenotype has also been described, featuring milder or absent neurological signs and a remitting pattern on neuroimaging. Mutations in four genes, MLC1, HEPACAM, GPRC5B and AQP4 have been associated with MLC. We describe clinical and genetic features of a cohort of genetically confirmed Italian MLC patients, representing the largest Italian cohort reported to date. MATERIALS AND

methodsWe conducted a retrospective, multicenter, observational study. Patients were included based on clinical and neuroimaging features consistent with MLC, along with a confirmed genetic diagnosis. Data were collected using a standardized database and included demographic, clinical, neuroimaging, neurophysiological, and genetic information.

resultsThirty-three patients from eight Italian centers were enrolled. Twenty-seven harbored biallelic MLC1 variants (23 distinct mutations, including three novel variants), while six had three distinct heterozygous HEPACAM variants. All MLC1-mutated patients exhibited the "classic" phenotype, frequently accompanied by orthopedic, gastrointestinal, and respiratory comorbidities. HEPACAM-mutated patients were consistent with the "improving" phenotype. No patients harbored mutations in GPRC5B or AQP4.

conclusionsOur findings expand the mutational spectrum of MLC1, further characterize the disease phenotype, and provide valuable insights into its presence in Italy. They also underscore management needs of individuals with MLC, highlighting the importance of multidisciplinary care.

Indexed as

CystsHereditary Central Nervous System Demyelinating DiseasesAdolescentAdultBrainCell Cycle ProteinsChildChild, PreschoolFemaleHumansInfantItalyMagnetic Resonance ImagingMaleMembrane ProteinsMiddle AgedCell Cycle ProteinsHEPACAM protein, humanMembrane ProteinsMLC1 protein, humanAQP4GPRC5BHEPACAMLeukodystrophyMLCMLC1

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.